Prestige Consumer Healthcare (PBH) Other Working Capital Changes (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Other Working Capital Changes of -$4.9 million for Q4 2025, down 174.08% year-over-year from $6.6 million in Q4 2024, and down 691.23% quarter-over-quarter from $821000.0 in Q3 2025.
Prestige Consumer Healthcare (PBH) Other Working Capital Changes (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Other Working Capital Changes history runs 16 years deep, the most recent figure standing at -$4.9 million for Q4 2025.
- In Q4 2025, Other Working Capital Changes fell 174.08% year-over-year to -$4.9 million; the TTM figure through Dec 2025 stood at $7.8 million (up 15225.49% YoY), while the FY2025 annual figure was -$4.7 million, down 156.67% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at -$4.9 million, down from $821000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $3.1 million in Q4 2020, with the low at $2000.0 in Q2 2022.
- The 5-year median for Other Working Capital Changes is $43000.0 (2021), against an average of $390000.0.
- The sharpest annual moves came in 2021 and 2022: Other Working Capital Changes soared 687.75% in 2021, then slumped 495.41% in 2022.
- Prestige Consumer Healthcare's Other Working Capital Changes stood at $3.1 million in 2020, then tumbled by 98.6% to $43000.0 in 2021, then plunged by 86.05% to $6000.0 in 2022, then jumped by 7366.67% to $448000.0 in 2023, then sank by 94.64% to $24000.0 in 2024.
- Business Quant data shows PBH's Other Working Capital Changes at $24000.0 in Q4 2024, $20000.0 in Q3 2024, and $944000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.85 Mn |
| Dec 31, 2025 | -4.85 Mn |
| Dec 31, 2025 | -4.85 Mn |
| Sep 30, 2025 | 821,000.00 |
| Sep 30, 2025 | 821,000.00 |
| Sep 30, 2025 | 821,000.00 |
| Jun 30, 2025 | 10.95 Mn |
| Jun 30, 2025 | 10.95 Mn |
| Jun 30, 2025 | 10.95 Mn |
| Mar 31, 2025 | 903,000.00 |
| Mar 31, 2025 | 903,000.00 |
| Mar 31, 2025 | 903,000.00 |
| Dec 31, 2024 | -1.77 Mn |
| Dec 31, 2024 | -1.77 Mn |
| Dec 31, 2024 | -1.77 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Jun 30, 2024 | -2.36 Mn |
| Jun 30, 2024 | -2.36 Mn |